Dbl-like Regulators of Small GTP-binding Proteins
Dbl-like Regulators of Small GTP-binding Proteins
批准号:
6925943
负责人:
YI ZHENG
金额:
$29.21万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-04-01 至 2009-03-31
关键词:
RNA interferenceapoptosisbiological signal transductionbone marrow transplantationcarcinogenesiscell adhesioncell migrationcell proliferationgene expressiongenetically modified animalsguanine nucleotide binding proteinguanine nucleotide exchange factorshematopoietic stem cellslaboratory mouseleukemiamolecular oncologyneoplasm /cancer geneticsp53 gene /proteinphysical modelprotein protein interactionprotein structure functionsmall molecule
中文摘要
描述(由申请人提供):该项目的长期目标是了解Dbl家族鸟嘌呤核苷酸交换因子(GEF)的信号传导机制,并研究GEF异常与人类疾病的关系。与Dbl相关的gef代表了一个大的细胞生长调节分子家族,有70多个哺乳动物成员。它们的细胞功能密切依赖于它们相互作用和激活特定Rho gtpase的能力,从而导致各种生理反应,包括细胞分裂、细胞运动、细胞增殖和存活。Dbl家族成员在羧基端与Pleckstrin-homology (PH)结构域串联具有Dbl-homology (DH)结构域的结构模块。先前的研究已经确定DH结构域负责Rho GTPase识别和GEF活性,而PH结构域与其他调控基序一起参与细胞内靶向和/或DH结构域功能的调节。为了继续我们上一个资助期的研究路线,我们计划追求三个具体目标,以检查GEF的致癌激活是否可能与癌症发展有关,并利用其机制特征设计干扰Dbl家族GEF信号传导的方法。在第一个目标中,我们将研究Dbl家族的两个成员,共同位点淋巴瘤/白血病GEF (Clg)和白血病相关Rho GEF (LARG)在生理和病理相关的原发性造血干细胞/祖细胞中的信号传导机制。在第二个目标中,我们将在小鼠移植模型中寻找Clg和MLL-LARG融合活化与白血病发生的功能关联。在第三个目标中,我们将基于结构-功能知识设计GEF-Rho GTPase相互作用的肽和小分子抑制剂。总之,这些机制和功能研究将为Dbl家族GEFs的生理/病理作用提供有价值的信息,并在Rho GTPase激活剂与人类病理状况(如癌症)之间建立密切联系。该结果也可能为干预gef介导的信号传导提供有价值的药理学试剂。
英文摘要
DESCRIPTION (provided by applicant): The long-term objectives of this project are to understand the signaling mechanisms of the Dbl family guanine nucleotide exchange factors (GEFs) and to examine the involvement of the GEF abnormalities in human diseases. The Dbl related GEFs represent a large family of cell growth regulatory molecules with over 70 mammalian members. Their cellular functions intimately depend on their ability to interact and activate specific Rho GTPases, leading to various physiological responses including cytokinesis, cell movement, cell proliferation and survival. The Dbl family members share the structural module of a Dbl-homology (DH) domain in tandem at the carboxyl terminus with a Pleckstrin-homology (PH) domain. Previous studies have established that the DH domain is responsible for Rho GTPase recognition and the GEF activity, whereas the PH domain, together with additional regulatory motifs, is involved in intracellular targeting and/or modulation of the DH domain function. To continue the lines of studies of our last funding period, we plan to pursue three specific aims to examine whether oncogenic activation of the GEFs might be associated with cancer development and to utilize the mechanistic features to devise ways to interfere with the Dbl family GEF signaling. In the first aim we will examine the signaling mechanisms of two members of the Dbl family, Common Site lymphoma/leukemia GEF (Clg) and Leukemia associated Rho GEF (LARG), in the physiologically and pathologically relevant primary hematopoietic stem/progenitor cells. In the second aim we will seek a functional association of Clg and the fusion MLL-LARG activation with leukemogenesis in a mouse transplant model. In the third aim we will devise peptide and small molecule inhibitors of the GEF-Rho GTPase interaction based on the structure-function knowledge. Together, these mechanistic and functional studies will provide valuable information on the physiological/pathological roles of Dbl family GEFs and draw a close connection between the Rho GTPase activators and human pathological conditions such as cancer. The results may also provide valuable pharmacological reagents for the intervention of the GEF-mediated signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10201886
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2021
-
负责人:YI ZHENG
-
依托单位:
Administrative Core
-
批准号:10458591
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2021
-
负责人:YI ZHENG
-
依托单位:
Administrative Core
-
批准号:10673644
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2021
-
负责人:YI ZHENG
-
依托单位:
Novel mechanism of intestinal stem cell aging
-
批准号:10436391
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:YI ZHENG
-
依托单位:
Novel mechanism of intestinal stem cell aging
-
批准号:10646426
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:YI ZHENG
-
依托单位:
Novel mechanism of intestinal stem cell aging
-
批准号:10263330
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2020
-
负责人:YI ZHENG
-
依托单位:
Targeting Cdc42 for bone marrow transplant therapies
-
批准号:9269547
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2015
-
负责人:YI ZHENG
-
依托单位:
Targeting Cdc42 for bone marrow transplant therapies
-
批准号:8856719
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2015
-
负责人:YI ZHENG
-
依托单位:
Multi-Photon Confocal Microscope
-
批准号:7839902
-
项目类别:
-
资助金额:$82.66万
-
财政年份:2011
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8509681
-
项目类别:
-
资助金额:$68.35万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8538702
-
项目类别:
-
资助金额:$2.32万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8054038
-
项目类别:
-
资助金额:$71.44万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8325286
-
项目类别:
-
资助金额:$3.28万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8150917
-
项目类别:
-
资助金额:$69.19万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8298260
-
项目类别:
-
资助金额:$72.47万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8704524
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8914791
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Cincinnati Center for Excellence in Molecular Hematology
-
批准号:8698741
-
项目类别:
-
资助金额:$69.19万
-
财政年份:2010
-
负责人:YI ZHENG
-
依托单位:
Rac GTPases as targets in lymphomagenesis
-
批准号:7834611
-
项目类别:
-
资助金额:$64.55万
-
财政年份:2009
-
负责人:YI ZHENG
-
依托单位:
Training program in hematologic and oncologic diseases
-
批准号:8132914
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2008
-
负责人:YI ZHENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: